PortfoliosLab logoPortfoliosLab logo
UNH vs. MRK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UNH vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UnitedHealth Group Incorporated (UNH) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UNH achieves a 21.95% return, which is significantly higher than MRK's 15.60% return. Over the past 10 years, UNH has outperformed MRK with an annualized return of 13.14%, while MRK has yielded a comparatively lower 11.69% annualized return.


UNH

1D
0.76%
1M
8.76%
YTD
21.95%
6M
22.48%
1Y
38.84%
3Y*
-4.57%
5Y*
1.42%
10Y*
13.14%

MRK

1D
0.44%
1M
6.37%
YTD
15.60%
6M
23.07%
1Y
61.27%
3Y*
6.37%
5Y*
13.79%
10Y*
11.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UNH vs. MRK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UNH
UnitedHealth Group Incorporated
21.95%-33.14%-2.41%0.80%6.94%45.20%21.25%20.00%14.52%39.83%
MRK
Merck & Co., Inc.
15.60%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%

Correlation

The correlation between UNH and MRK is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.24

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.32

Correlation (All Time)
Calculated using the full available price history since Mar 27, 1990

0.28

The correlation between UNH and MRK shifts across timeframes, from 0.19 (3 years) to 0.32 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

UNH:

$363.52B

MRK:

$298.59B

EPS

UNH:

$13.23

MRK:

$3.58

PE Ratio

UNH:

30.20

MRK:

33.70

PS Ratio

UNH:

0.81

MRK:

4.59

PB Ratio

UNH:

3.50

MRK:

6.51

Total Revenue (TTM)

UNH:

$449.71B

MRK:

$65.59B

Gross Profit (TTM)

UNH:

$84.55B

MRK:

$49.79B

EBITDA (TTM)

UNH:

$22.99B

MRK:

$22.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UNH vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UNH
UNH Risk / Return Rank: 6767
Overall Rank
UNH Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
UNH Sortino Ratio Rank: 6464
Sortino Ratio Rank
UNH Omega Ratio Rank: 6868
Omega Ratio Rank
UNH Calmar Ratio Rank: 6767
Calmar Ratio Rank
UNH Martin Ratio Rank: 6666
Martin Ratio Rank

MRK
MRK Risk / Return Rank: 9090
Overall Rank
MRK Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 9090
Sortino Ratio Rank
MRK Omega Ratio Rank: 8787
Omega Ratio Rank
MRK Calmar Ratio Rank: 9292
Calmar Ratio Rank
MRK Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UNH vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UnitedHealth Group Incorporated (UNH) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UNHMRKDifference
Sharpe ratioReturn per unit of total volatility

-1.29

Sortino ratioReturn per unit of downside risk

-1.79

Omega ratioGain probability vs. loss probability

1.22

1.39

-0.17

Calmar ratioReturn relative to maximum drawdown

1.35

5.42

-4.07

Martin ratioReturn relative to average drawdown

2.95

13.58

-10.63

UNH vs. MRK - Sharpe Ratio Comparison

The current UNH Sharpe Ratio is 0.97, which is lower than the MRK Sharpe Ratio of 2.26. The chart below compares the historical Sharpe Ratios of UNH and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


UNHMRKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.97

2.26

-1.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.04

0.58

-0.54

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

0.51

-0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

0.64

0.48

+0.15

Drawdowns

UNH vs. MRK - Drawdown Comparison

The maximum UNH drawdown since its inception was -74.37%, which is greater than MRK's maximum drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for UNH and MRK.


Loading charts...

Drawdown Indicators


UNHMRKDifference

Max Drawdown

Largest peak-to-trough decline

-74.37%

-68.61%

-5.76%

Max Drawdown (1Y)

Largest decline over 1 year

-28.96%

-11.37%

-17.59%

Max Drawdown (3Y)

Largest decline over 3 years

-61.39%

-43.44%

-17.95%

Max Drawdown (5Y)

Largest decline over 5 years

-61.39%

-43.44%

-17.95%

Max Drawdown (10Y)

Largest decline over 10 years

-61.39%

-43.44%

-17.95%

Current Drawdown

Current decline from peak

-33.78%

-3.64%

-30.14%

Average Drawdown

Average peak-to-trough decline

-14.76%

-18.84%

+4.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.19%

4.52%

+8.67%

Volatility

UNH vs. MRK - Volatility Comparison

The current volatility for UnitedHealth Group Incorporated (UNH) is 8.18%, while Merck & Co., Inc. (MRK) has a volatility of 9.45%. This indicates that UNH experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UNHMRKDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.18%

9.45%

-1.27%

Volatility (6M)

Calculated over the trailing 6-month period

30.89%

18.16%

+12.73%

Volatility (1Y)

Calculated over the trailing 1-year period

40.16%

27.28%

+12.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.86%

23.71%

+8.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.18%

22.96%

+7.22%

Dividends

UNH vs. MRK - Dividend Comparison

UNH's dividend yield for the trailing twelve months is around 2.21%, less than MRK's 2.75% yield.


PositionTTM20252024202320222021202020192018201720162015
MRK
Merck & Co., Inc.
2.75%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%
UNH
UnitedHealth Group Incorporated
2.21%2.64%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%

Financials

UNH vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between UnitedHealth Group Incorporated and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B100.00B120.00B20222023202420252026
111.72B
16.29B
(UNH) Total Revenue
(MRK) Total Revenue
Values in USD except per share items

UNH vs. MRK - Profitability Comparison

The chart below illustrates the profitability comparison between UnitedHealth Group Incorporated and Merck & Co., Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
22.7%
81.9%
Portfolio components
UNH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, UnitedHealth Group Incorporated reported a gross profit of 25.41B and revenue of 111.72B. Therefore, the gross margin over that period was 22.7%.

MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

UNH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, UnitedHealth Group Incorporated reported an operating income of 8.99B and revenue of 111.72B, resulting in an operating margin of 8.1%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

UNH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, UnitedHealth Group Incorporated reported a net income of 6.28B and revenue of 111.72B, resulting in a net margin of 5.6%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.


Frequently Asked Questions


UNH and MRK have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MRK has higher volatility (9.45%) compared to UNH (8.18%). In terms of maximum drawdown, UNH dropped -74.37% vs MRK's -68.61%.

MRK currently has the higher Sharpe Ratio (2.26 vs 0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UNH and MRK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer